Ultragenyx Pharmaceutical (RARE) Net Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,401.00 |
| Dec 31, 2025 | 5,078.00 |
| Sep 30, 2025 | -4,376.00 |
| Jun 30, 2025 | 3,959.00 |
| Mar 31, 2025 | -36,907.00 |
| Dec 31, 2024 | 35,615.00 |
| Sep 30, 2024 | -621.00 |
| Jun 30, 2024 | 6,732.00 |
| Mar 31, 2024 | -5,966.00 |
| Dec 31, 2023 | 6,565.00 |
| Sep 30, 2023 | -1,525.00 |
| Jun 30, 2023 | 1,560.00 |
| Mar 31, 2023 | -1,466.00 |
| Dec 31, 2022 | 12,173.00 |
| Sep 30, 2022 | -9,320.00 |
| Jun 30, 2022 | 1,353.00 |
| Mar 31, 2022 | -4,091.00 |
| Dec 31, 2021 | -6,024.00 |
| Sep 30, 2021 | 5,136.00 |
| Jun 30, 2021 | -379.00 |
| Mar 31, 2021 | -11,074.00 |
| Dec 31, 2020 | 5,827.00 |
| Sep 30, 2020 | -12,553.00 |
| Jun 30, 2020 | 36,883.00 |
| Mar 31, 2020 | -6,426.00 |
| Dec 31, 2019 | 17,441.00 |
| Sep 30, 2019 | -2,729.00 |
| Jun 30, 2019 | 12,178.00 |
| Mar 31, 2019 | 766.00 |
| Dec 31, 2018 | 20,214.00 |
| Sep 30, 2018 | -33,011.00 |
| Jun 30, 2018 | -69,548.00 |
| Mar 31, 2018 | 494,892.00 |
| Dec 31, 2017 | 3.53 Mn |
| Dec 31, 2016 | -136.66 Mn |
| Sep 30, 2016 | 27.64 Mn |